WebDisclosure WebDisclosure
Basculer en Français
10238 Companies
211363 Keywords
141296 Articles
111973 Press releases
Headlines Articles Press releases HEXAOM Remove
  1. Home
  2. Companies
  3. HEXAOM
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/09/2024 at 19:35, 2 years ago

    Hexaom Announces Strong Financial Results for 2023, Despite Market Challenges

    Revenue Growth Market Challenges Operating Profitability Financial Results 2023 Hexaom
  • BRIEF

    published on 04/09/2024 at 19:35, 2 years ago

    Hexaom annonce de solides résultats financiers pour 2023, malgré les défis du marché

    Rentabilité Opérationnelle Résultats Financiers 2023 Hausse Des Revenus Défis Du Marché Hexaom
  • PRESS RELEASE

    published on 04/09/2024 at 19:30, 2 years ago

    2023 RESULTS MARKED BY GROWTH

    Hexaom reports strong financial results for 2023 with revenue up 6.3% to €1,024.4 million. Operating income increased by 20.4% and net income from continuing operations by 40.9%. Outlook for 2024 remains positive
    Financial Results Revenue 2024 Outlook Operating Income Hexaom
    Logo of HEXAOM
Previous page
1 ... 18 19
Accesswire
  • Published on 04/18/2026 at 04:00, 1 day 3 hours ago

    Formation Metals Responds to OTC Markets Request on Recent Promotional Activity

  • Published on 04/18/2026 at 02:00, 1 day 5 hours ago

    AI/ML Innovations Announces Completion of Share Issuance

  • Published on 04/18/2026 at 01:35, 1 day 5 hours ago

    Medicure Announces Resignation of President and Chief Operating Officer

  • Published on 04/18/2026 at 01:00, 1 day 6 hours ago

    Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development

  • Published on 04/18/2026 at 00:00, 1 day 7 hours ago

    Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia

View all ACCESSWIRE
EQS Group
  • Published on 04/18/2026 at 00:05, 1 day 7 hours ago

    ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds

  • Published on 04/17/2026 at 21:39, 1 day 9 hours ago

    Linedata Services: Mise à disposition du Document d’Enregistrement Universel 2025 incluant le Rapport Financier Annuel 2025

  • Published on 04/17/2026 at 20:33, 1 day 10 hours ago

    LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors

  • Published on 04/17/2026 at 19:35, 1 day 11 hours ago

    Stabilisation Notice

  • Published on 04/17/2026 at 19:30, 1 day 11 hours ago

    KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS

View all EQS
Les Echos
  • Published on 04/17/2026 at 20:30, 1 day 10 hours ago

    ALTAREA - Déclaration d’opérations sur actions propres

  • Published on 04/17/2026 at 19:00, 1 day 12 hours ago

    Cegedim : Publication du Document d’Enregistrement Universel 2025

  • Published on 04/17/2026 at 19:00, 1 day 12 hours ago

    Cegedim: Release of its 2025 Universal Registration Document

  • Published on 04/17/2026 at 17:45, 1 day 13 hours ago

    Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın

  • Published on 04/17/2026 at 17:45, 1 day 13 hours ago

    Carrefour annonce la cession de sa participation minoritaire dans CarrefourSA en Turquie à Aydın

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy